04-22-2010 10:10 AM CET - Health & Medicine
Print PDF Email

Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm

Press release from: Diapharm
PR Agency: co-operate Wegener & Rieke GmbH
Dr. Thomas Baierl is the new team leader of Regulatory Affairs Pharma at Diapharm.
Dr. Thomas Baierl is the new team leader of Regulatory Affairs Pharma at Diapharm.
(openPR) - Münster (Germany), 20 April 2010. By hiring Dr. Thomas Baierl, Diapharm (diapharm.com) has added to its staff at the Münster location as of 1 April 2010. At the same time, the pharmaceutical industry service provider is improving its ability to provide consultancy services for prescription medicinal products. Baierl, who has a doctorate in biology, is taking over management of the Regulatory Affairs Pharma team at Diapharm. Together with his team members, he will be advising manufacturers of medicinal products on national and international regulatory issues. He will also be helping to build up and manage the associated quality dossiers.

"I am proud to be working with an excellent regulatory affairs team at Diapharm, and I hope to continue to add to our services at this high level", explains the 46-year-old, who is looking forward to his work at the internationally operating full-service provider. Diapharm has been helping pharmaceutical companies with all aspects of regulatory affairs, medicine & clinical development, quality and business development since it was founded in 1988.

Dr. Thomas Baierl brings 14 years of experience in regulatory affairs to Diapharm. Until March 2010, as the manager responsible for regulatory affairs, he led a team for haemophilia and oncology medicinal products at Wyeth Pharma GmbH, a Pfizer Group company. Baierl received his doctorate from the University of Karlsruhe.

Contact:
Diapharm GmbH
Press Office
Hafenweg 18-20
D-48155 Münster

Contact person:
Nicole Sibbing

Tel.: +49 (0)251 60935-17
nicole.sibbing@diapharm.com
www.diapharm.com

Agency contact:
co-operate Wegener & Rieke GmbH
Zumsandestrasse 32
D-48145 Münster

Contact person:
Christian Rieke

Tel.: +49 (0)251 3222611
wort@co-operate.net
www.co-operate.net

Diapharm is a full-service provider to the healthcare industry. Founded in 1988, Diapharm supports pharmaceutical companies in all questions concerning regulatory affairs, medical & clinical development, quality and business development. Its activities focus on the sectors of medicinal products, food supplements and dietetic food, medical devices and cosmetics. With about 100 employees, Diapharm is at the service of multinational companies as well as of recent start-ups and small to mid-sized businesses.
News-ID: 128126
del.icio.us:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine MisterWong:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine Digg:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine StumbleUpon:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine Technorati:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine Reddit:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine Furl:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine WebNews:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine OneView:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine LinkArena:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine YiGG:Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm - Pressreleases - openPR - Health & Medicine
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.